Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Department of Biobehavioral Nursing and Health Informatics, University of Washington School of Nursing, Seattle, WA, USA.
Eur J Heart Fail. 2021 Oct;23(10):1712-1721. doi: 10.1002/ejhf.2207. Epub 2021 Jun 6.
There is conflicting evidence whether heart failure (HF) is a risk factor for incident cancer. Despite population-based cohorts demonstrating this association, an analysis of the Physician's Health Study found no association in a cohort of mostly healthy males. We investigated the association of HF with incident cancer among a large cohort of post-menopausal women.
A prospective cohort study of 146 817 post-menopausal women age 50 to 79 years enrolled in the Women's Health Initiative from 1993-1998, and followed through 2015. The primary exposure was adjudicated incident HF diagnosis, including preserved and reduced ejection fraction in a sub-cohort. The primary outcome was adjudicated incident total and site-specific cancers. Hazard ratios were calculated using multivariable-adjusted Cox proportional hazard regression models. Over a median follow-up of 8.4 years, 3272 and 17 474 women developed HF and cancer, respectively. HF developed in 235 women prior to cancer. HF was associated with subsequent incident cancer [hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.11-1.48]. Associations were observed for obesity-related cancers (HR 1.24, 95% CI 1.02-1.51), as well as lung and colorectal cancers (HR 1.58, 95% CI 1.09-2.30 and HR 1.52, 95% CI 1.02-2.27, respectively). HF with preserved ejection fraction (HR 1.34, 95% CI 1.06-1.67), but not HF reduced ejection fraction (HR 0.99, 95% CI 0.74-1.34), was associated with total cancer.
Heart failure was associated with an increase in cancer diagnoses in post-menopausal women. This association was strongest for lung cancer. Further research is needed to appreciate the underlying mechanisms responsible for this association.
心力衰竭(HF)是否是癌症发病的危险因素存在争议。尽管基于人群的队列研究表明存在这种关联,但对大多数健康男性的医师健康研究分析并未发现这种关联。我们调查了 HF 与绝经后女性中癌症发病的关联。
这是一项前瞻性队列研究,纳入了 1993 年至 1998 年参加妇女健康倡议的 146817 名年龄在 50 至 79 岁之间的绝经后妇女,并随访至 2015 年。主要暴露为经裁决的 HF 发病诊断,亚组中包括射血分数保留和射血分数降低。主要结局为经裁决的总癌症和特定部位癌症。使用多变量调整的 Cox 比例风险回归模型计算危险比。在中位随访 8.4 年期间,3272 名和 17474 名女性分别发生 HF 和癌症。235 名女性在癌症发生前发生 HF。HF 与随后的癌症发病相关[风险比(HR)1.28,95%置信区间(CI)1.11-1.48]。观察到与肥胖相关的癌症(HR 1.24,95%CI 1.02-1.51),以及肺癌和结直肠癌(HR 1.58,95%CI 1.09-2.30 和 HR 1.52,95%CI 1.02-2.27)的关联。射血分数保留的 HF(HR 1.34,95%CI 1.06-1.67),而射血分数降低的 HF(HR 0.99,95%CI 0.74-1.34)与总癌症相关。
HF 与绝经后妇女癌症诊断增加相关。这种关联在肺癌中最强。需要进一步研究以了解导致这种关联的潜在机制。